Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1995 Oct;72(4):1043–1046. doi: 10.1038/bjc.1995.459

Haemoccult test properties according to type and number of positive slides in mass screening for colorectal cancer.

G Launoy 1, C Herbert 1, J M Reaud 1, Y Thezee 1, J Tichet 1, J Maurel 1, V Ollivier 1, L Pegulu 1, E Caces 1, A Valla 1, et al.
PMCID: PMC2034039  PMID: 7547220

Abstract

Despite encouraging results from recent studies, there is still no consensus to undertake mass screening using the Haemoccult test in the general population. The success of mass screening for colorectal cancer depends among other things on Haemoccult test properties. In on-going screening programmes, the Haemoccult test consists of six slides and a test is considered positive if at least one slide is coloured. The aim of this work was to study the influence of the type and number of positive slides on the Haemoccult test's positive predictive value and characteristics of screened lesions. This work focuses on 63,958 first tests in a mass screening programme in Calvados (France) among people aged 45-74 years. There was a linear relation between the positive predictive value for cancer or an adenoma larger than 1 cm and the number of positive slides (P < 10(-4)). The positive predictive value for cancer or large adenoma was significantly higher when 4-6 slides were positive (44.3%) than when only 1-3 were positive (19.1%) (P < 10(-4)). In this latter group, the subjects in whom tumours were detected were younger and had significantly less extensive cancers. Borderline tests (no slides positive and at least one slide with a blue coloration confined to the edges) had a positive predictive value for cancer or an adenoma larger than 1 cm no different to that of tests with 1-3 positive slides. Subjects with borderline results were markedly younger than the others and had less extensive cancers and rectal localisation more often than the others. Our results suggest that (1) increasing the number of positive slides required to declare a test positive leads to an increase in the positive predictive value but is not to be recommended because of the sensitivity of the test and (2) considering borderline Haemoccult tests as positive in on-going and future mass screening campaigns would allow an increase in the sensitivity of the test, especially for rectal cancer and low extensive tumours without any decrease in its positive predictive value.

Full text

PDF
1043

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bedenne L., Durand G., Faivre J., Milan C., Boutron M. C., Arveux P., Colombier P., Klepping C. Résultats préliminaires d'une campagne de dépistage de masse du cancer colorectal. Gastroenterol Clin Biol. 1990;14(2):140–145. [PubMed] [Google Scholar]
  2. Gilbertsen V. A., McHugh R., Schuman L., Williams S. E. The earlier detection of colorectal cancers: a preliminary report of the results of the Occult Blood Study. Cancer. 1980 Jun 1;45(11):2899–2901. doi: 10.1002/1097-0142(19800601)45:11<2899::aid-cncr2820451132>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  3. Hardcastle J. D., Thomas W. M., Chamberlain J., Pye G., Sheffield J., James P. D., Balfour T. W., Amar S. S., Armitage N. C., Moss S. M. Randomised, controlled trial of faecal occult blood screening for colorectal cancer. Results for first 107,349 subjects. Lancet. 1989 May 27;1(8648):1160–1164. doi: 10.1016/s0140-6736(89)92750-5. [DOI] [PubMed] [Google Scholar]
  4. Jensen B. M., Kronborg O., Fenger C. Interval cancers in screening with fecal occult blood test for colorectal cancer. Scand J Gastroenterol. 1992 Sep;27(9):779–782. doi: 10.3109/00365529209011183. [DOI] [PubMed] [Google Scholar]
  5. Kronborg O., Fenger C., Olsen J., Bech K., Søndergaard O. Repeated screening for colorectal cancer with fecal occult blood test. A prospective randomized study at Funen, Denmark. Scand J Gastroenterol. 1989 Jun;24(5):599–606. doi: 10.3109/00365528909093096. [DOI] [PubMed] [Google Scholar]
  6. Mandel J. S., Bond J. H., Bradley M., Snover D. C., Church T. R., Williams S., Watt G., Schuman L. M., Ederer F., Gilbertsen V. Sensitivity, specificity, and positive predictivity of the Hemoccult test in screening for colorectal cancers. The University of Minnesota's Colon Cancer Control Study. Gastroenterology. 1989 Sep;97(3):597–600. doi: 10.1016/0016-5085(89)90629-x. [DOI] [PubMed] [Google Scholar]
  7. Mandel J. S., Bond J. H., Church T. R., Snover D. C., Bradley G. M., Schuman L. M., Ederer F. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med. 1993 May 13;328(19):1365–1371. doi: 10.1056/NEJM199305133281901. [DOI] [PubMed] [Google Scholar]
  8. Robinson M. H., Thomas W. M., Pye G., Hardcastle J. D., Mangham C. M. Is dietary restriction always necessary in Haemoccult screening for colorectal neoplasia? Eur J Surg Oncol. 1993 Dec;19(6):539–542. [PubMed] [Google Scholar]
  9. Selby J. V., Friedman G. D., Quesenberry C. P., Jr, Weiss N. S. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med. 1992 Mar 5;326(10):653–657. doi: 10.1056/NEJM199203053261001. [DOI] [PubMed] [Google Scholar]
  10. Simon J. B. Occult blood screening for colorectal carcinoma: a critical review. Gastroenterology. 1985 Mar;88(3):820–837. doi: 10.1016/0016-5085(85)90158-1. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES